By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


SEARCH JOBS








Company News
Aurinia (ISA.TO) Highlights Renal Function Data From Global Phase IIb AURA Study Of Voclosporin For Lupus Nephritis At American Society of Nephrology Kidney Week 2016 11/21/2016 11:01:53 AM
Aurinia (ISA.TO) Highlights Speed Of Remission From Global Phase IIb AURA Study Of Voclosporin In Lupus Nephritis At 2016 American College of Rheumatology Annual Meeting 11/16/2016 8:28:43 AM
Aurinia (ISA.TO) Establishes At-The-Market Facility 11/10/2016 2:46:39 PM
Aurinia (ISA.TO) Reports Third Quarter 2016 Financial Results And Operational Highlights 11/7/2016 10:28:42 AM
Aurinia (ISA.TO) Announces Plans For Single Phase III Clinical Trial For Voclosporin In The Treatment Of Lupus Nephritis Following Successful Completion Of End Of Phase II Meeting With FDA 11/3/2016 11:05:41 AM
Aurinia (ISA.TO) To Present At The 2016 BIO Investor Forum In San Francisco On October 18, 2016 10/11/2016 11:50:11 AM
Aurinia (ISA.TO) Releases Open-Label AURION Data Demonstrating Increased Remission Rates Over Time For Voclosporin In The Treatment Of Lupus Nephritis 10/6/2016 7:43:09 AM
Aurinia (ISA.TO) Announces That Voclosporin Achieves Primary And All Pre-Specified Secondary Endpoints In Its Phase IIb AURA-LV Study For Lupus Nephritis (LN) 9/30/2016 9:39:28 AM
Aurinia (ISA.TO) To Present At The Leerink Partners Roundtable Series In New York September 28, 2016 9/22/2016 11:11:45 AM
Aurinia (ISA.TO) To Host Lupus Nephritis (LN) Breakfast And Webcast On September 30th In New York 9/21/2016 11:15:15 AM
12345678910...
//-->